Evicenter
MarkdownMedical informationP&T meetings
Inaxaplin (VX-147)

APOL1-mediated kidney disease

Launch
Not announced
Last updated
162 sources

Product information and disease descriptionProduct descriptionProduct informationDosing and administration

Dosage

7 evidence topics · 7 sources

Maximum daily dose, total dose, and treatment duration in the EU trial record
FieldQuoted record
Maximum daily dose“45 mg milligram(s)”
Maximum total dose“4860 mg milligram(s)”
Maximum duration of treatment“108 week(s)”